SUPER GROUP SGHC LTD (SGHC) Fundamental Analysis & Valuation

NYSE:SGHC • GG00BMG42V42

Current stock price

10.58 USD
-0.35 (-3.2%)
At close:
10.44 USD
-0.14 (-1.32%)
Pre-Market:

This SGHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. SGHC Profitability Analysis

1.1 Basic Checks

  • In the past year SGHC was profitable.
  • SGHC had positive earnings in 4 of the past 5 years.
  • In the past 5 years SGHC always reported a positive cash flow from operatings.
SGHC Yearly Net Income VS EBIT VS OCF VS FCFSGHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

1.2 Ratios

  • The Return On Assets of SGHC (11.90%) is better than 87.30% of its industry peers.
  • Looking at the Return On Equity, with a value of 19.98%, SGHC belongs to the top of the industry, outperforming 80.16% of the companies in the same industry.
  • SGHC has a Return On Invested Capital of 34.32%. This is amongst the best in the industry. SGHC outperforms 97.62% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for SGHC is significantly above the industry average of 10.56%.
  • The 3 year average ROIC (15.79%) for SGHC is below the current ROIC(34.32%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.9%
ROE 19.98%
ROIC 34.32%
ROA(3y)10.16%
ROA(5y)16.96%
ROE(3y)17.87%
ROE(5y)59.56%
ROIC(3y)15.79%
ROIC(5y)31.82%
SGHC Yearly ROA, ROE, ROICSGHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 100 150

1.3 Margins

  • SGHC has a better Profit Margin (6.41%) than 65.08% of its industry peers.
  • In the last couple of years the Profit Margin of SGHC has declined.
  • SGHC's Operating Margin of 15.43% is fine compared to the rest of the industry. SGHC outperforms 68.25% of its industry peers.
  • SGHC's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 15.43%
PM (TTM) 6.41%
GM N/A
OM growth 3Y-8.81%
OM growth 5YN/A
PM growth 3Y-28%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SGHC Yearly Profit, Operating, Gross MarginsSGHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. SGHC Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SGHC is creating value.
  • The number of shares outstanding for SGHC has been increased compared to 1 year ago.
  • The number of shares outstanding for SGHC has been increased compared to 5 years ago.
  • The debt/assets ratio for SGHC is higher compared to a year ago.
SGHC Yearly Shares OutstandingSGHC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
SGHC Yearly Total Debt VS Total AssetsSGHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 10.53 indicates that SGHC is not in any danger for bankruptcy at the moment.
  • SGHC has a better Altman-Z score (10.53) than 96.83% of its industry peers.
  • SGHC has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
  • SGHC has a better Debt to Equity ratio (0.11) than 79.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 10.53
ROIC/WACC3.86
WACC8.88%
SGHC Yearly LT Debt VS Equity VS FCFSGHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

  • A Current Ratio of 1.58 indicates that SGHC should not have too much problems paying its short term obligations.
  • SGHC has a better Current ratio (1.58) than 73.02% of its industry peers.
  • SGHC has a Quick Ratio of 1.58. This is a normal value and indicates that SGHC is financially healthy and should not expect problems in meeting its short term obligations.
  • SGHC has a Quick ratio of 1.58. This is in the better half of the industry: SGHC outperforms 76.98% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
SGHC Yearly Current Assets VS Current LiabilitesSGHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. SGHC Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 127.13% over the past year.
  • The earnings per share for SGHC have been decreasing by -21.17% on average. This is quite bad
  • SGHC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.20%.
  • SGHC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 28.06% yearly.
EPS 1Y (TTM)127.13%
EPS 3Y-21.17%
EPS 5YN/A
EPS Q2Q%27.56%
Revenue 1Y (TTM)18.2%
Revenue growth 3Y5.54%
Revenue growth 5Y28.06%
Sales Q2Q%-4.65%

3.2 Future

  • Based on estimates for the next years, SGHC will show a very strong growth in Earnings Per Share. The EPS will grow by 48.47% on average per year.
  • Based on estimates for the next years, SGHC will show a quite strong growth in Revenue. The Revenue will grow by 15.01% on average per year.
EPS Next Y65.32%
EPS Next 2Y68.89%
EPS Next 3Y48.47%
EPS Next 5YN/A
Revenue Next Year31.63%
Revenue Next 2Y22.6%
Revenue Next 3Y18.15%
Revenue Next 5Y15.01%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SGHC Yearly Revenue VS EstimatesSGHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
SGHC Yearly EPS VS EstimatesSGHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

4

4. SGHC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 35.27, which means the current valuation is very expensive for SGHC.
  • Compared to the rest of the industry, the Price/Earnings ratio of SGHC is on the same level as its industry peers.
  • When comparing the Price/Earnings ratio of SGHC to the average of the S&P500 Index (26.91), we can say SGHC is valued slightly more expensively.
  • A Price/Forward Earnings ratio of 12.56 indicates a correct valuation of SGHC.
  • Based on the Price/Forward Earnings ratio, SGHC is valued a bit cheaper than 78.57% of the companies in the same industry.
  • SGHC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.68.
Industry RankSector Rank
PE 35.27
Fwd PE 12.56
SGHC Price Earnings VS Forward Price EarningsSGHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • SGHC's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.46
SGHC Per share dataSGHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of SGHC may justify a higher PE ratio.
  • SGHC's earnings are expected to grow with 48.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.54
PEG (5Y)N/A
EPS Next 2Y68.89%
EPS Next 3Y48.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. SGHC Dividend Analysis

5.1 Amount

  • SGHC has a Yearly Dividend Yield of 1.63%. Purely for dividend investing, there may be better candidates out there.
  • SGHC's Dividend Yield is a higher than the industry average which is at 1.14.
  • SGHC's Dividend Yield is comparable with the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 1.63%

5.2 History

  • SGHC has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
SGHC Yearly Dividends per shareSGHC Yearly Dividends per shareYearly Dividends per share 2024 2025 2026 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

DPN/A
EPS Next 2Y68.89%
EPS Next 3Y48.47%
SGHC Yearly Income VS Free CF VS DividendSGHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

More info and screens

Find the best dividend stocksShow peers with best dividend

SGHC Fundamentals: All Metrics, Ratios and Statistics

SUPER GROUP SGHC LTD

NYSE:SGHC (4/9/2026, 8:04:00 PM)

Premarket: 10.44 -0.14 (-1.32%)

10.58

-0.35 (-3.2%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-03
Earnings (Next)05-06
Inst Owners19.09%
Inst Owner Change0%
Ins Owners4.59%
Ins Owner Change0%
Market Cap5.35B
Revenue(TTM)1.84B
Net Income(TTM)132.89M
Analysts84.29
Price Target17.72 (67.49%)
Short Float %9.5%
Short Ratio5.5
Dividend
Industry RankSector Rank
Dividend Yield 1.63%
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date03-16
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.17%
Min Revenue beat(2)8.12%
Max Revenue beat(2)10.23%
Revenue beat(4)3
Avg Revenue beat(4)5.25%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)10.23%
Revenue beat(8)6
Avg Revenue beat(8)5.18%
Revenue beat(12)10
Avg Revenue beat(12)6.37%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.42%
PT rev (3m)-1.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE 35.27
Fwd PE 12.56
P/S 2.58
P/FCF N/A
P/OCF N/A
P/B 8.04
P/tB 12.8
EV/EBITDA 12.46
EPS(TTM)0.3
EY2.84%
EPS(NY)0.84
Fwd EY7.96%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.1
BVpS1.32
TBVpS0.83
PEG (NY)0.54
PEG (5Y)N/A
Graham Number2.98
Profitability
Industry RankSector Rank
ROA 11.9%
ROE 19.98%
ROCE 43.44%
ROIC 34.32%
ROICexc 73.64%
ROICexgc 263.12%
OM 15.43%
PM (TTM) 6.41%
GM N/A
FCFM N/A
ROA(3y)10.16%
ROA(5y)16.96%
ROE(3y)17.87%
ROE(5y)59.56%
ROIC(3y)15.79%
ROIC(5y)31.82%
ROICexc(3y)34.14%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.99%
ROCE(5y)40.28%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.96%
ROICexc growth 5YN/A
OM growth 3Y-8.81%
OM growth 5YN/A
PM growth 3Y-28%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA 0.17
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z 10.53
F-ScoreN/A
WACC8.88%
ROIC/WACC3.86
Cap/Depr(3y)74.88%
Cap/Depr(5y)56.11%
Cap/Sales(3y)3.76%
Cap/Sales(5y)2.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)127.13%
EPS 3Y-21.17%
EPS 5YN/A
EPS Q2Q%27.56%
EPS Next Y65.32%
EPS Next 2Y68.89%
EPS Next 3Y48.47%
EPS Next 5YN/A
Revenue 1Y (TTM)18.2%
Revenue growth 3Y5.54%
Revenue growth 5Y28.06%
Sales Q2Q%-4.65%
Revenue Next Year31.63%
Revenue Next 2Y22.6%
Revenue Next 3Y18.15%
Revenue Next 5Y15.01%
EBIT growth 1Y202.71%
EBIT growth 3Y-3.76%
EBIT growth 5YN/A
EBIT Next Year136.41%
EBIT Next 3Y48.54%
EBIT Next 5Y34.33%
FCF growth 1Y142.01%
FCF growth 3Y-1.1%
FCF growth 5Y295.28%
OCF growth 1Y113.54%
OCF growth 3Y7.33%
OCF growth 5Y137.97%

SUPER GROUP SGHC LTD / SGHC Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SUPER GROUP SGHC LTD (SGHC) stock?

ChartMill assigns a fundamental rating of 6 / 10 to SGHC.


Can you provide the valuation status for SUPER GROUP SGHC LTD?

ChartMill assigns a valuation rating of 4 / 10 to SUPER GROUP SGHC LTD (SGHC). This can be considered as Fairly Valued.


Can you provide the profitability details for SUPER GROUP SGHC LTD?

SUPER GROUP SGHC LTD (SGHC) has a profitability rating of 6 / 10.


What is the financial health of SUPER GROUP SGHC LTD (SGHC) stock?

The financial health rating of SUPER GROUP SGHC LTD (SGHC) is 5 / 10.